FDA testosterone therapy label changes may expand eligibility, remove cardiovascular warnings, and update prostate cancer and BPH guidance based on newer safety evidence.

Awiqli, also known as insulin icodec, is a once-weekly basal insulin approved for adults with type 2 diabetes. It may help reduce the burden of daily insulin injections while supporting A1c reduction, but careful dosing and patient education are essential.

More than 350 cases of Lyme disease, Delaware’s most common tick-borne disease, were reported in 2025, reinforcing why tick prevention matters across the state.